Pediatric Ulcerative Colitis Clinical Trial
Official title:
A Phase I/II Open-Label, Proof-of-Concept Study of Vamorolone in Children and Adolescents With Mild-Moderately Active Ulcerative Colitis
This is a Phase I/II, multi-center, open-label proof-of-concept study of vamorolone. Twenty participants with a flare of mild or moderately active Ulcerative Colitis (defined as a Pediatric Ulcerative Colitis Activity Index [PUCAI] 10-60) will be enrolled and receive vamorolone 6 mg/kg/day orally once daily for 8 weeks.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05673278 -
Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
|
||
Completed |
NCT05591976 -
Exercise Training in Youth With Inflammatory Bowel Disease
|
N/A | |
Terminated |
NCT03827109 -
Peer Mentoring to Improve Self-management in Youth With IBD
|
N/A | |
Completed |
NCT01585155 -
Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
|
Phase 3 | |
Terminated |
NCT02694042 -
Mission is Remission®: How Can a Disease Self-management Website Change Care?
|
N/A |